Case: 21-2024 Document: 55 Page: 1 Filed: 02/15/2022
NOTE: This disposition is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
AMARIN PHARMA, INC., AMARIN
PHARMACEUTICALS IRELAND LIMITED,
Plaintiffs
EPA DRUG INITIATIVE II,
Movant-Appellant
v.
HIKMA PHARMACEUTICALS USA INC., HIKMA
PHARMACEUTICALS INTERNATIONAL LIMITED,
WEST-WARD PHARMACEUTICALS
INTERNATIONAL LIMITED, DR. REDDY'S
LABORATORIES, INC., DR. REDDY'S
LABORATORIES, LTD.,
Defendants-Appellees
______________________
2021-2024
______________________
Appeal from the United States District Court for the
District of Nevada in Nos. 2:16-cv-02525-MMD-NJK, 2:16-
cv-02562-MMD-NJK, Judge Miranda M. Du.
______________________
JUDGMENT
______________________
Case: 21-2024 Document: 55 Page: 2 Filed: 02/15/2022
MICHAEL S. KASANOFF, I, Michael S. Kasanoff, LLC,
Matawan, NJ, argued for movant-appellant.
CHARLES B. KLEIN, Winston & Strawn LLP, Washing-
ton, DC, for defendants-appellees Hikma Pharmaceuticals
USA Inc., Hikma Pharmaceuticals International Limited,
West-Ward Pharmaceuticals International Limited. Also
represented by CLAIRE A. FUNDAKOWSKI; ALISON MICHELLE
KING, Chicago, IL; EIMERIC REIG-PLESSIS, San Francisco,
CA.
JAMES BARABAS, Windels Marx Lane & Mittendorf,
LLP, Madison, NJ, argued for all defendants-appellees.
Defendants-appellees Dr. Reddy's Laboratories, Inc., Dr.
Reddy's Laboratories, Ltd. also represented by BETH C.
FINKELSTEIN, CONSTANCE HUTTNER, CAROLINE SUN.
______________________
THIS CAUSE having been heard and considered, it is
ORDERED and ADJUDGED:
PER CURIAM (NEWMAN, DYK, and REYNA, Circuit
Judges).
AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY ORDER OF THE COURT
February 15, 2022 /s/ Peter R. Marksteiner
Date Peter R. Marksteiner
Clerk of Court